Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Christopoulos, Dean of the Faculty of Pharmaceutical Sciences at Monash University, is at the centre of a significant ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Dr. Kimberly Doyle from Baylor Scott & White shares valuable tips to ward off cognitive decline and keep your mind sharp as ...

CA stem cell clinics offering unproven treatments for arthritis and Alzheimer’s will come under FDA regulation after a 9th Circuit ruling.

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

Kisunla is a 0nce-a-month, 30-minute infusion that is shown to slow the progression of the disease by 37 percent and reduce Alzheimer's-causing plaques by 84 percent.

ROCHESTER, Minn. - Alzheimer's, it's a disease that impacts millions of Americans. On Oct. 1, Mayo Clinic hosted an 'After ...

The Alzheimer’s Association is working toward a future free of Alzheimer’s and dementia, with a clear mission to advance ...

GE HealthCare has secured the FDA’s approval for an injectable, radioactive imaging agent that gives clinicians a clearer ...